The proliferation of HCT116 human CRC cells was markedly reduced by inhibition of HSPG2 gene expression by the antisense cDNA, and these effects correlated with a decreased sensitivity to FGF-7x [42]. The gene discussed is HSPG2; the disease is colorectal carcinoma.